Total Funding
58
77
Total FundingPre-Seed raised
Growth Score
-4 pts
Heat Score
11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
65240
MultivisionDx develops AI-powered oncology software that analyzes medical data to support cancer diagnosis and treatment selection.
- Michael Wittinger: Chief Executive Officer
- Karolina Punovuori: Co-Founder & CSO
About the Company
MultivisionDx develops AI-powered oncology software designed to support cancer diagnosis and personalized treatment selection. Its platform analyzes medical imaging and clinical data to identify tumor characteristics and generate insights that assist healthcare teams. By combining artificial intelligence with precision medicine, the company aims to
enhance diagnostic accuracy and support more informed cancer care decisions.
